T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer

    NEXT STORY
    Turning Point Therapeutics Announces Management Transition
    PREV STORY
    Chembio Diagnostics Announces CEO Transition
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XBiotech to Attend and Present at the ASCO 2016 Gastrointestinal Cancers Symposium

    AUSTIN, Texas, Jan. 21, 2016 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT), developer of True Human™ ...

    author_avatar
    NASDAQ Market News

    Chembio’s DPP® Zika IgM/IgG Assay Obtains CE Mark for Rapid Point-of-Care Detection of Zika Virus

    MEDFORD, N.Y., July 27, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

    author_avatar
    NASDAQ Market News

    ETST Announces the Execution of a Binding LOI to Acquire 100% of the Assets of a Canadian Biotech Company Specializing in Medical Devices, Testing and Vaccines and Forms New Wholly Owned Subsidiary, Earth Science Pharmaceutical, Inc.

    Boca Raton, June 20, 2016 (GLOBE NEWSWIRE) --  Earth Science Tech, Inc. (OTCQB: ETST) ...

    author_avatar
    NASDAQ Market News